TFBS BioscienceROCO:6939 49 OCF Margin % is 5.83% as of Dec. 2025, which is 63% below its 10-year median of 15.86. GuruFocus rates ROCO:6939 with a GF Score™ of 49/100 and a GF Value™ of NT$32.16 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, TFBS Bioscience ranks worse than 62.75% on this metric.
The historical rank and industry rank for TFBS Bioscience's OCF Margin % or its related term are showing as below:
ROCO:6939'
s OCF Margin % Range Over the Past 10 Years
Min: -5.04 Med: 15.86 Max: 31.15
Current: -5.04
During the past 6 years, the highest OCF Margin % of TFBS Bioscience was 31.15%. The lowest was -5.04%. And the median was 15.86%.
ROCO:6939's OCF Margin % is ranked worse than 62.75% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs ROCO:6939: -5.04
TFBS Bioscience OCF Margin % Related Terms
TFBS Bioscience OCF Margin % Historical Data
* Premium members only.
The historical data trend for TFBS Bioscience's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6939 vs TMO, DHR, IDXX: OCF Margin % Comparison
For the Diagnostics & Research subindustry, TFBS Bioscience's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TFBS Bioscience OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's OCF Margin % distribution charts can be found below:
* The bar in red indicates where TFBS Bioscience's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TFBS Bioscience (ROCO:6939) has a OCF Margin % of 5.83% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TFBS Bioscience and its competitors. This is 63% below median its historical median of 15.86. According to the industry distribution chart, TFBS Bioscience ranks #128 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 62.7%.
Is TFBS Bioscience's OCF Margin % too high?
TFBS Bioscience's current OCF Margin % of 5.83% is 63% below median its 10-year median of 15.86. The Medical Diagnostics & Research industry median OCF Margin % is 4.76. TFBS Bioscience's value of 5.83% is 22.6% above this industry median. Based on the distribution chart, TFBS Bioscience ranks #128 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, TFBS Bioscience has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, TFBS Bioscience ranks #128 out of 204 companies for OCF Margin %. This places TFBS Bioscience in the lower half of its industry. The industry median OCF Margin % is 4.76. TFBS Bioscience's value of 5.83% is 22.6% above this benchmark. While the company's 10-year median is 15.86 vs. the industry median of 4.76, TFBS Bioscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TFBS Bioscience's current OCF Margin % of 5.83% is 22.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on TFBS Bioscience and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TFBS Bioscience's current OCF Margin % is 5.83%, which is 63% below median its own 10-year median of 15.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$32.16, compared to a current price of NT$20.70 — trading 35.6% below its estimated fair value. The current OCF Margin % is 5.83%, which is 63% below median its 10-year median of 15.86 and 22.6% above the Medical Diagnostics & Research industry median of 4.76. TFBS Bioscience's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current OCF Margin % is 5.83% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?
Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued.
The current stock price of NT$20.70 is trading 35.6% below its estimated GF Value™ of NT$32.16.
GuruFocus considers TFBS Bioscience to be Possible Value Trap.
Key valuation signals for ROCO:6939:
OCF Margin %: 5.83% (63% below median its 10-year median of 15.86)
GF Value™: NT$32.16 vs. price of NT$20.70 (35.6% below fair value)
Industry Position: 22.6% above the Medical Diagnostics & Research median (#128 of 204)
No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
49GF Score
Get the complete analysis for ROCO:6939
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6939 has been successfully added to your 
